[1] [3] Crucially for weight management, these medications act on receptors in the hypothalamus and brainstem areas that regulate appetite and satiety, leading to reduced hunger, increased feelings of fullness, and decreased food intake
15, 16 GLP-1, endogenously produced in the L-cells of the distal ileum and colon, modulates appetite leading to decreased food intake and thus body weight
This varies based on BMI for Semaglutide , adherence to the program, and lifestyle habits
More than 100 preclinical studies have examined the peptide in models of gut injury, tendon and ligament repair, blood vessel formation, and nervous system damage